Indeed, cancer tissue can express fibrinolytic proteins, such as the plasminogen activators (urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA)), their inhibitors (PAI-1 and -2), and their receptors. This evidence concerns the gene SERPINE1 and cancer.